Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Abilify Injection now available

Dec. 14, 2006

ESPRIT technology focus of new program in Duchenne muscular dystrophy

Dec. 14, 2006

TRO-19622 well tolerated at doses expected to be effective

Dec. 14, 2006

Erythropoietin benefits amyotrophic lateral sclerosis patients

Dec. 14, 2006

No statistical significance for nalmefene on endpoints in pathological gambling

Dec. 14, 2006

DanioLabs reports encouraging progress in Parkinson's disease programs

Dec. 14, 2006

New Rebif formulation studied in phase III

Dec. 13, 2006

Recent patents disclose new therapeutic agents for anxiety, depression, etc.

Dec. 13, 2006

Clinical hold lifted on MEM-3454

Dec. 13, 2006

TRO-19622 successfully completes phase Ib studies

Dec. 13, 2006

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...